Patent | Date |
---|
Antibodies against vascular endothelial growth factor receptor-1 Grant 8,143,025 - Wu , et al. March 27, 2 | 2012-03-27 |
Antibodies Against Vascular Endothelial Growth Factor Receptor-1 App 20110269186 - WU; Yan ;   et al. | 2011-11-03 |
Antibodies against vascular endothelial growth factor receptor-1 Grant 7,972,596 - Wu , et al. July 5, 2 | 2011-07-05 |
Antibodies Against Vascular Endothelial Growth Factor Receptor-1 App 20100028347 - Wu; Yan ;   et al. | 2010-02-04 |
Antibody Antagonists Of Ve-cadherin Without Adverse Effects On Vascular Permeability App 20090060909 - LIAO; Fang ;   et al. | 2009-03-05 |
Antibody Antagonists Of Ve-cadherin Without Adverse Effects On Vascular Permeability App 20080317750 - LIAO; Fang ;   et al. | 2008-12-25 |
Antibody Antagonists Of Ve-cadherin Without Adverse Effects On Vascular Permeability App 20080311121 - Liao; Fang ;   et al. | 2008-12-18 |
Antibody antagonists of VE-cadherin without adverse effects on vascular permeability Grant 7,371,574 - Liao , et al. May 13, 2 | 2008-05-13 |
Method and composition for inhibiting heparanase activity App 20040247577 - Bohlen, Peter ;   et al. | 2004-12-09 |
Antibody antagonists of VE-cadherin without adverse effects on vascular permeability App 20020160003 - Liao, Fang ;   et al. | 2002-10-31 |
Stabilization of fibroblast growth factors by modification of cysteine residues Grant 6,010,999 - Daley , et al. January 4, 2 | 2000-01-04 |
Stabilization of somatotropins and other proteins by modification of cysteine residues Grant 5,951,972 - Daley , et al. September 14, 1 | 1999-09-14 |
Methods for inhibiting proliferation of tumor cells and tumor growth Grant 5,856,315 - Backer , et al. January 5, 1 | 1999-01-05 |
Methods for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth Grant 5,843,925 - Backer , et al. December 1, 1 | 1998-12-01 |
Therapeutic compositions and methods for use of heparin-binding brain mitogens Grant 5,641,743 - Bohlen , et al. June 24, 1 | 1997-06-24 |
Methods for inhibiting angiogenesis proliferation of endothelial or tumor cells and tumor growth Grant 5,574,026 - Backer , et al. November 12, 1 | 1996-11-12 |
Method for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth Grant 5,567,693 - Backer , et al. October 22, 1 | 1996-10-22 |
Bovine basic fibroblast growth factor Grant 5,464,774 - Baird , et al. November 7, 1 | 1995-11-07 |
Active fragments of fibroblast growth factor Grant 5,387,673 - Seddon , et al. February 7, 1 | 1995-02-07 |
Chimeric fibroblast growth factors Grant 5,310,883 - Seddon , et al. May 10, 1 | 1994-05-10 |
Human MK gene and method of expression Grant 5,210,026 - Kovesdi , et al. May 11, 1 | 1993-05-11 |
Heparin-binding brain mitogens Grant 5,171,842 - Bohlen , et al. December 15, 1 | 1992-12-15 |
Basic fibroblast growth factor Grant 5,155,214 - Baird , et al. * October 13, 1 | 1992-10-13 |
Isolation of fibroblast growth factor Grant 4,785,079 - Gospodarowicz , et al. November 15, 1 | 1988-11-15 |
Purification of T-cell growth factor Grant 4,675,383 - Bohlen , et al. June 23, 1 | 1987-06-23 |
Ovine GRF Grant 4,605,643 - Bohlen , et al. August 12, 1 | 1986-08-12 |
Bovine GRF Grant 4,585,756 - Brazeau, Jr. , et al. April 29, 1 | 1986-04-29 |
Mammalian PGRF Grant 4,517,181 - Ling , et al. May 14, 1 | 1985-05-14 |
Extended N-terminal somatostatin Grant 4,316,891 - Guillemin , et al. February 23, 1 | 1982-02-23 |